Friedl-Naderer Johanna sold DYN

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001915598-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Aug 13, 2026

Published

Aug 17, 2026

Ingested by INSIDER

Nov 5, 02:22 UTC

Last re-read

Nov 5, 02:22 UTC

Extracted facts

Filer

Friedl-Naderer Johanna

Role

Chief Commercial Officer

Transaction

Open-market saleAs filed: “S”

Asset

Dyne Therapeutics, Inc.

Ticker

DYN

Shares

226

Price per share

$26.28

Value

$5,939

Execution date (reported)

Aug 13, 2026

Owned after transaction

154.0K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

4

Calculation

What this establishes

Friedl-Naderer Johanna filed this Form 4 reporting a open-market sale of DYN on Aug 13, 2026. It became public on Aug 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Commercial Officer

Friedl-Naderer Johannacik:0001915598

Issuer

Dyne Therapeutics, Inc.cik:0001818794

Revision history · 0

No field has changed since this record was first ingested.